Institutional investors purchased a net $1.3 million shares of BGMD during the quarter ended June 2014, and now own 12.91% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WOODSTOCK CORP. Sold 14.8 Thousand shares of BG Medicine Inc